BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 26753533)

  • 1. An intact Pms2 ATPase domain is not essential for male fertility.
    Fischer JM; Dudley S; Miller AJ; Liskay RM
    DNA Repair (Amst); 2016 Mar; 39():46-51. PubMed ID: 26753533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in the expression profile of the meiosis-involved mismatch repair genes in impaired human spermatogenesis.
    Terribas E; Bonache S; García-Arévalo M; Sánchez J; Franco E; Bassas L; Larriba S
    J Androl; 2010; 31(4):346-57. PubMed ID: 20075417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Truncation of the C-terminus of human MLH1 blocks intracellular stabilization of PMS2 and disrupts DNA mismatch repair.
    Mohd AB; Palama B; Nelson SE; Tomer G; Nguyen M; Huo X; Buermeyer AB
    DNA Repair (Amst); 2006 Mar; 5(3):347-61. PubMed ID: 16338176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contributions by MutL homologues Mlh3 and Pms2 to DNA mismatch repair and tumor suppression in the mouse.
    Chen PC; Dudley S; Hagen W; Dizon D; Paxton L; Reichow D; Yoon SR; Yang K; Arnheim N; Liskay RM; Lipkin SM
    Cancer Res; 2005 Oct; 65(19):8662-70. PubMed ID: 16204034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conservation of functional asymmetry in the mammalian MutLα ATPase.
    Johnson JR; Erdeniz N; Nguyen M; Dudley S; Liskay RM
    DNA Repair (Amst); 2010 Nov; 9(11):1209-13. PubMed ID: 20864418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Meiotic arrest and aneuploidy in MLH3-deficient mice.
    Lipkin SM; Moens PB; Wang V; Lenzi M; Shanmugarajah D; Gilgeous A; Thomas J; Cheng J; Touchman JW; Green ED; Schwartzberg P; Collins FS; Cohen PE
    Nat Genet; 2002 Aug; 31(4):385-90. PubMed ID: 12091911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nuclear import of human MLH1, PMS2, and MutLalpha: redundancy is the key.
    Leong V; Lorenowicz J; Kozij N; Guarné A
    Mol Carcinog; 2009 Aug; 48(8):742-50. PubMed ID: 19148896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MutLα heterodimers modify the molecular phenotype of Friedreich ataxia.
    Ezzatizadeh V; Sandi C; Sandi M; Anjomani-Virmouni S; Al-Mahdawi S; Pook MA
    PLoS One; 2014; 9(6):e100523. PubMed ID: 24971578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessing pathogenicity of MLH1 variants by co-expression of human MLH1 and PMS2 genes in yeast.
    Vogelsang M; Comino A; Zupanec N; Hudler P; Komel R
    BMC Cancer; 2009 Oct; 9():382. PubMed ID: 19863800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of Lynch syndrome mutations in the MLH1-PMS2 interface that disturb dimerization and mismatch repair.
    Kosinski J; Hinrichsen I; Bujnicki JM; Friedhoff P; Plotz G
    Hum Mutat; 2010 Aug; 31(8):975-82. PubMed ID: 20533529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated levels of the mismatch repair protein PMS2 are associated with prostate cancer.
    Norris AM; Woodruff RD; D'Agostino RB; Clodfelter JE; Scarpinato KD
    Prostate; 2007 Feb; 67(2):214-25. PubMed ID: 17044039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differing patterns of genetic instability in mice deficient in the mismatch repair genes Pms2, Mlh1, Msh2, Msh3 and Msh6.
    Hegan DC; Narayanan L; Jirik FR; Edelmann W; Liskay RM; Glazer PM
    Carcinogenesis; 2006 Dec; 27(12):2402-8. PubMed ID: 16728433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different mutator phenotypes in Mlh1- versus Pms2-deficient mice.
    Yao X; Buermeyer AB; Narayanan L; Tran D; Baker SM; Prolla TA; Glazer PM; Liskay RM; Arnheim N
    Proc Natl Acad Sci U S A; 1999 Jun; 96(12):6850-5. PubMed ID: 10359802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Localization of MMR proteins on meiotic chromosomes in mice indicates distinct functions during prophase I.
    Kolas NK; Svetlanov A; Lenzi ML; Macaluso FP; Lipkin SM; Liskay RM; Greally J; Edelmann W; Cohen PE
    J Cell Biol; 2005 Nov; 171(3):447-58. PubMed ID: 16260499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multivariate analysis of MLH1 c.1664T>C (p.Leu555Pro) mismatch repair gene variant demonstrates its pathogenicity.
    Farrell MP; Hughes DJ; Drost M; Wallace AJ; Cummins RJ; Fletcher TA; Meany MA; Kay EW; de Wind N; Power DG; Andrews EJ; Green AJ; Gallagher DJ
    Fam Cancer; 2013 Dec; 12(4):741-7. PubMed ID: 23712482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenetic repression of DNA mismatch repair by inflammation and hypoxia in inflammatory bowel disease-associated colorectal cancer.
    Edwards RA; Witherspoon M; Wang K; Afrasiabi K; Pham T; Birnbaumer L; Lipkin SM
    Cancer Res; 2009 Aug; 69(16):6423-9. PubMed ID: 19638594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA mismatch repair and colon cancer.
    Marra G; Jiricny J
    Adv Exp Med Biol; 2005; 570():85-123. PubMed ID: 18727499
    [No Abstract]   [Full Text] [Related]  

  • 18. Apoptosis and mutation in the murine small intestine: loss of Mlh1- and Pms2-dependent apoptosis leads to increased mutation in vivo.
    Sansom OJ; Bishop SM; Court H; Dudley S; Liskay RM; Clarke AR
    DNA Repair (Amst); 2003 Sep; 2(9):1029-39. PubMed ID: 12967659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concomitant mutation and epimutation of the MLH1 gene in a Lynch syndrome family.
    Cini G; Carnevali I; Quaia M; Chiaravalli AM; Sala P; Giacomini E; Maestro R; Tibiletti MG; Viel A
    Carcinogenesis; 2015 Apr; 36(4):452-8. PubMed ID: 25742745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA mismatch repair deficiency in breast carcinoma: a pilot study of triple-negative and non-triple-negative tumors.
    Wen YH; Brogi E; Zeng Z; Akram M; Catalano J; Paty PB; Norton L; Shia J
    Am J Surg Pathol; 2012 Nov; 36(11):1700-8. PubMed ID: 22992699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.